Investment Q&A

• InMode Ltd. (INMD $14.44)
  • $14.44 Cap: $1B
  • View INMD Profile
  • View Questions on INMD

Q: This stock is down over 50%. Should I hold, sell, or add more. Your view. Thanks

Upvote 0

Read Answer Asked by Vinod on March 02, 2022

• Castlecap Capital Inc. (CSTL.P $0.05)
  • View CSTL.P Profile
  • View Questions on CSTL.P

Q: The market seems to like the Q4 release - higher rev's and lower losses, though still not profitable. CSTL looks like they are doing the right things, the acquisitions seem to have future potential. How would you read this for an investment with the year end results and guidance?

Upvote 0

Read Answer Asked by Harry on March 02, 2022

• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Good morning guys,
Are u folk in agreement here with mr zinberg in regards to his comments with this name .. this guy worked with donville so he’s certainly well respected as a stock picker so as a owner of this name should we be concerned here .. already down significantly .. hold , add , or sell please..

Upvote 0

Read Answer Asked by Mark on March 02, 2022

• Sernova Biotherapeutics Inc. (SVA $0.15)
  • $0.15 Cap: $48M
  • View SVA Profile
  • View Questions on SVA
• Amgen Inc. (AMGN $326.10)
  • $326.10 P/E (TTM): 25.18X Cap: $175.59B
  • View AMGN Profile
  • View Questions on AMGN
• Regeneron Pharmaceuticals Inc. (REGN $796.55)
  • $796.55 P/E (TTM): 19.05X Cap: $83.71B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $463.86)
  • $463.86 P/E (TTM): 32.44X Cap: $117.69B
  • View VRTX Profile
  • View Questions on VRTX
• Profound Medical Corp. (PRN $11.71)
  • $11.71 Cap: $351M
  • View PRN Profile
  • View Questions on PRN

Q: I have dabbled in a few mid to small cap Canadian bio companies over the years. I never have the stomach to hold on for the long term in general due to high volatility but I like the sector. I'm currently sitting on Sernova (SVA) for now at least. How Do you like them? Do you have any other recommendations in this sector?

Upvote 0

Read Answer Asked by DAVE on March 02, 2022

• Pfizer Inc. (PFE $25.48)
  • $25.48 P/E (TTM): 14.81X Cap: $144.87B
  • View PFE Profile
  • View Questions on PFE
• Biohaven Ltd. (BHVN $11.11)
  • $11.11 Cap: $1.17B
  • View BHVN Profile
  • View Questions on BHVN

Q: I notice BHVN made a deal with PFE recently. Their stock has dropped since and was wondering if you could shed some light on why, I would have thought it would have been positive for them.
Generally what are your thoughts on BHVN as an investment?
Thanks John

Upvote 0

Read Answer Asked by John on March 01, 2022

• Viatris Inc. (VTRS $12.76)
  • $12.76 Cap: $14.69B
  • View VTRS Profile
  • View Questions on VTRS

Q: Would you be a buyer of Viatris after the 22% drop today?

Upvote 0

Read Answer Asked by Edward on March 01, 2022

• Codexis Inc. (CDXS $1.64)
  • $1.64 Cap: $153M
  • View CDXS Profile
  • View Questions on CDXS
• Twist Bioscience Corporation (TWST $35.32)
  • $35.32 Cap: $2.16B
  • View TWST Profile
  • View Questions on TWST

Q: thoughts on the 2 companies. thanks

Upvote 0

Read Answer Asked by cliff on February 28, 2022

• CloudMD Software & Services Inc. (DOC $0.04)
  • View DOC Profile
  • View Questions on DOC

Q: just on fundamentals is this buisnes on sale?

Upvote 0

Read Answer Asked by cliff on February 28, 2022

• AbCellera Biologics Inc. (ABCL $4.37)
  • $4.37 Cap: $1.28B
  • View ABCL Profile
  • View Questions on ABCL

Q: I believe earnings were out last week. Could you give me your opinion on the earnings and the company.
Thanks John

Upvote 0

Read Answer Asked by John on February 28, 2022

• Theratechnologies Inc. (TH $4.47)
  • $4.47 Cap: $205M
  • View TH Profile
  • View Questions on TH

Q: Please comment on latest earnings and provide your opinion on this company's outlook. Thanks.

Upvote 0

Read Answer Asked by Ray on February 25, 2022

• Amgen Inc. (AMGN $326.10)
  • $326.10 P/E (TTM): 25.18X Cap: $175.59B
  • View AMGN Profile
  • View Questions on AMGN
• Regeneron Pharmaceuticals Inc. (REGN $796.55)
  • $796.55 P/E (TTM): 19.05X Cap: $83.71B
  • View REGN Profile
  • View Questions on REGN
• Vertex Pharmaceuticals Incorporated (VRTX $463.86)
  • $463.86 P/E (TTM): 32.44X Cap: $117.69B
  • View VRTX Profile
  • View Questions on VRTX
• Mettler-Toledo International Inc. (MTD $1,485.12)
  • $1,485.12 P/E (TTM): 37.08X Cap: $30.33B
  • View MTD Profile
  • View Questions on MTD

Q: I'm hearing that pharma and biotech company valuations are at multi year lows. With one chart showing the percentage of US biotechs with market caps below cash value is at a 25 year high, and by a wide margin. Do you feel this sector shows a big opportunity to get good companies for cheap in a sector that will one day improve? If so what companies look best to you in Canada or US? Are there any sectors that are more beaten up? Thx

Upvote 0

Read Answer Asked by Adam on February 23, 2022

• Teladoc Health Inc. (TDOC $7.46)
  • $7.46 Cap: $1.32B
  • View TDOC Profile
  • View Questions on TDOC

Q: There earning came out yesterday,please analysis.Is there any chance of getting back some what where it was in 2 3 yrs?
tnx u.....

Upvote 0

Read Answer Asked by tom on February 23, 2022

• Hamilton Thorne Ltd. (HTL $2.24)
  • View HTL Profile
  • View Questions on HTL

Q: Please comment on HTL's Q4 and 2021 results released today.

Upvote 0

Read Answer Asked by John on February 18, 2022

• Knight Therapeutics Inc. (GUD $5.98)
  • $5.98 Cap: $596M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Thanks for the prompt reply. What were the sales for the previous two quarters?

Upvote 0

Read Answer Asked by Steven on February 17, 2022

• Knight Therapeutics Inc. (GUD $5.98)
  • $5.98 Cap: $596M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Do you have an imminent quarterly reporting date for Knight and any results expectations would be appreciated. Thank you.

Upvote 0

Read Answer Asked by Steven on February 17, 2022

• Quipt Home Medical Corp. (QIPT $4.92)
  • $4.92 Cap: $216M
  • View QIPT Profile
  • View Questions on QIPT

Q: What is your take on the quarter? Is the company on a cash burn rate or generating free cashflow if you normalize or remove acquisitions? Thanks

Upvote 0

Read Answer Asked by Scott on February 17, 2022

• Jamieson Wellness Inc. (JWEL $34.21)
  • $34.21 P/E (TTM): 24.09X Cap: $1.43B
  • View JWEL Profile
  • View Questions on JWEL

Q: YOUR CURRENT OPINION ON JAMIESON WELLNES

Upvote 0

Read Answer Asked by Karen on February 16, 2022

• Neighbourly Pharmacy Inc. (NBLY $18.60)
  • View NBLY Profile
  • View Questions on NBLY

Q: Hi,

Could you comment on NBLY’s earnings? How did they do vs analyst expectations?

Thanks
Peter

Upvote 0

Read Answer Asked by Peter on February 16, 2022

• 1Life Healthcare Inc. (ONEM)
  • View ONEM Profile
  • View Questions on ONEM

Q: Hello,
Can I get an update on 1 Life Healthcare. Would you buy at these levels? Can I get one alternative healthcare stock that you would recommend instead. Investment horizon is 3-5 years.
Thank-you.

Upvote 0

Read Answer Asked by Antonio on February 16, 2022

• Reliq Health Technologies Inc. (RHT)
  • Cap: $47M
  • View RHT Profile
  • View Questions on RHT

Q: Can you please give an update on RHT. Would you consider it a buy, sell or hold at these levels.

Upvote 0

Read Answer Asked by Bruce on February 15, 2022